Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

Cochrane database of systematic reviews (Online)

Volumn , Issue 2, 2006, Pages

  Webster, A C ^a   Lee, V W ^a   Chapman, J R ^a   Craig, J C ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS;

EID: 33745013619     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (69)